Bromodomain-containing protein 2
BRD2proteinBRD2 suppresses ischemia-reperfusion injury and cardiomyocyte death, reducing myocardial infarction severity.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleCardioprotective factor limiting ischemia-reperfusion injury and myocardial damage after coronary occlusion.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates6
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000204256
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- BRD2 protects the rat H9C2 cardiomyocytes from hypoxia‑reoxygenation injury by targeting Nrf2/HO‑1 signaling pathway.Experimental and therapeutic medicine · 2023 · PMID 37869639 · doi